Product NDC: | 52533-002 |
Proprietary Name: | Hydromorphone HCl |
Non Proprietary Name: | Hydromorphone HCl |
Active Ingredient(s): | .2 mg/mL & nbsp; Hydromorphone HCl |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52533-002 |
Labeler Name: | Cantrell Drug Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100823 |
Package NDC: | 52533-002-10 |
Package Description: | 30 mL in 1 VIAL, GLASS (52533-002-10) |
NDC Code | 52533-002-10 |
Proprietary Name | Hydromorphone HCl |
Package Description | 30 mL in 1 VIAL, GLASS (52533-002-10) |
Product NDC | 52533-002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydromorphone HCl |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100823 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Cantrell Drug Company |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |